Insider Holders & Insider Ownership - Fulcrum Therapeutics Inc. (FULC)

List of insiders holdings for Fulcrum Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
2024-09-23 16:15:29 0
18,729,099
18,729,099 Form 3
2 LEVIN MARK J
Director
10% Owner
2021-11-12 17:31:37 75,800
4,970,625
5,046,425 Form 4
3 Third Rock Ventures IV L.P.
Third Rock Ventures GP IV L.P.
TRV GP IV LLC
10% Owner
2020-02-05 16:33:55 2,343,154
0
2,343,154 Form 13G
4 Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
10% Owner
2024-02-14 16:19:04 2,343,154
0
2,343,154 Form 13G
5 Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
TEPPER ROBERT I
10% Owner
2024-02-14 16:19:04 2,343,154
0
2,343,154 Form 13G
6 GLAXOSMITHKLINE PLC
10% Owner
2021-09-27 06:01:18 1,785,714
0
1,785,714 Form 13G
7 Casdin Capital LLC
Casdin Partners Master Fund L.P.
Casdin Partners GP LLC
Casdin Eli
10% Owner
2021-02-11 10:23:04 1,241,176
0
1,241,176 Form 13G
8 Sapir Alex
See Remarks
2025-01-28 16:15:11 582,000
0
582,000 Form 4
9 6 Dimensions Capital L.P.
10% Owner
2019-07-22 16:32:02 559,821
0
559,821 Form 4
10 Sanofi
10% Owner
2019-07-29 10:13:05 558,035
0
558,035 Form 13G
11 Section 32 Fund 2 LP
Section 32 GP 2 LLC
Maris William J
10% Owner
2019-07-22 16:30:46 464,285
0
464,285 Form 4
12 Horn Patrick Taylor
Chief Medical Officer
2024-03-20 16:15:10 400,000
0
400,000 Form 4
13 Arroyo Santiago
Chief Medical Officer
2022-11-09 16:15:14 400,000
0
400,000 Form 4
14 Stuart Bryan
See Remarks
2022-01-21 16:15:24 340,000
0
340,000 Form 4
15 Musso Alan A
Chief Financial Officer
2025-01-28 16:15:14 285,000
0
285,000 Form 4
16 Oltmans Curtis Gale
Chief Legal Officer
2025-01-28 16:15:06 225,000
0
225,000 Form 4
17 Wallace Owen B.
Chief Scientific Officer
2020-09-14 16:19:08 209,030
0
209,030 Form 4
18 Moxham Christopher
Chief Scientific Officer
2021-08-12 16:20:57 176,073
0
176,073 Form 4
19 Rajavelu Esther
Chief Financial Officer
2023-02-13 16:15:14 160,000
0
160,000 Form 4
20 Dunn Judith
See Remarks
2022-01-21 16:15:31 140,890
0
140,890 Form 4
21 Hayes Melvin H. III
Chief Operating Officer
2023-04-28 16:17:16 115,000
0
115,000 Form 4
22 Tourangeau Greg
Principal Accounting Officer
2025-01-28 16:15:08 76,120
0
76,120 Form 4
23 Cadavid Diego
SVP Clinical Development
2020-07-02 16:19:30 65,714
0
65,714 Form 4
24 King Rachel K.
Director
2024-11-14 16:15:03 60,000
0
60,000 Form 4
25 Hill Colin
Director
2024-06-18 16:15:04 60,000
0
60,000 Form 4
26 Morabito Christopher
Chief Medical Officer
2022-01-21 16:15:17 59,744
0
59,744 Form 4
27 Thomson Peter G.
VP Finance & Accounting
2022-01-21 16:15:41 40,000
0
40,000 Form 4
28 Dorton Katina
Director
2024-06-18 16:20:07 30,000
0
30,000 Form 4
29 GERAGHTY JAMES A
Director
2024-06-18 16:20:09 30,000
0
30,000 Form 4
30 Haviland Kate
Director
2024-06-18 16:20:13 30,000
0
30,000 Form 4
31 Gould Robert J
Director
2024-06-18 16:20:14 30,000
0
30,000 Form 4
32 Ezekowitz Alan
Director
2024-06-18 16:20:20 30,000
0
30,000 Form 4
33 Collins James J.
Director
2024-06-18 16:20:06 30,000
0
30,000 Form 4
34 Banks Sonja
Director
2024-06-18 16:20:03 30,000
0
30,000 Form 4